Free Newsletter
UK group pilots anti-counterfeit program
Pilot runs of an electronic drug tracking and authentication program have been completed successfully by SecureTrace, a U.K. drug counterfeit-fighting syndicate. The program, led by authentication solutions provider Authentix, traces each step of a drug's supply-chain journey.
The starting point is a high-speed packaging line at drugmaker Reckitt Benckiser. Drugs get a unique and secure 2-D barcode imprint that contains authentication markers in the ink. A laser surface authentication system then generates a fingerprint. Pack data is assembled into cartons, which are marked with barcodes and RFID labels.
A master database stores the ID information; field readers provide authentication and verification of the product throughout the supply chain.
Separately, the Rx-360 pharmaceutical supply-chain consortium has launched an audit-sharing pilot program to collect audit reports and data from 30 suppliers in North America, Europe, China and India. The idea is to make available suppliers' existing audit data to sponsors, so drugmakers can better gauge what additional auditing--if any--they need to do. The pilot's objective is to see how useful audit sharing is to consortium members.
- here's the SecureTrace release
- see the Rx-360 article
Related Articles:
Pundit ranks supply chain leaders
ISPE conference content highlights supply chain
Anticounterfeiting group hits the fast lane
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: